Abstract
Normal mental functions can be disrupted by many kinds of drugs. Hallucinogens are of special interest because of their ability to impair higher centers without producing substantial effect on other functions of the central nervous system. While the mechanism of action of hallucinogens has not been clarified, the striking structural resemblance between certain of these agents and several central nervous system transmitters has not gone unnoticed (Osmond and Smythies, 1952; Snyder and Merril, 1965). Mescaline, for example, bears a strong structural similarity to dopamine, and, among indoles, N,N-dimethyltryptamine and bufotenin resemble serotonin (Figure 1). The hallucinogenic properties of these biogenic amine congeners are well documented for mescaline (Kapadia and Fayez, 1970) and for the indoles (Fujimori and Alpers, 1970).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberici, M., Rodriquez de Lores Arnaiz, G., and De Robertis, E., 1965, Catechol-O-methyltransferase in nerve ending of rat brain, life Sci. 4: 1954
Armstrong, M. D., McMillan, A., and Shaw, K. N. F., 1957, 3-methoxy-4-hydroxy-D-mandelic Acid, a urinary metabolite of norepinephrine, Biochim. Biophys. Acta 25: 422.
Assicot, M., and Bohuon, C., 1971, Presence of two distinct catechol-O-methyltransferase activities in red blood cells, Biochimie 53: 871.
Axelrod, J., 1957, O-Methylation of epinephrine and other catechols in vitro and in vivo, Science 126: 400.
Axelrod, J., 1961, Enzymatic formation of psychotomimetic metabolites from normally occurring compounds, Science 134: 343.
Axelrod, J., 1965, The formation and metabolism of physiologically active compounds by Nand O-methyltransferases, in: Transmethylation and Methionine Biosynthesis ( S. K. Shapiro, and F. Schlenk, eds.), p. 71, University of Chicago Press, Chicago.
Axelrod, J., and Vesell, E. S., 1970, Heterogeneity of N- and O-methyltransferases, Mol. Pharmacol. 6: 78.
Barbeau, A., Singh, P., and Joubert, M., 1966, Effect of 3,4-dimethoxyphenylethylamine injections on catecholamine metabolism in rats and monkeys, Life Sci. 5: 757.
Benington, F., and Morin, R. D., 1968, Enzymatic 5-hydroxylation of 3-methoxytyramine Experientia 24:33.
Bindler, E., Sanghvi, I., and Gershon, S., 1968, Pharmacological and behavioral characteristics of 3,4-dimethoxyphenylethylamine and its N-acetyl derivative, Arch. Intern. Pharmacodyn. 176:1.
Blaschke, E., and Hertting, G., 1971, Enzymic methylation of L-ascorbic acid by catechol-Omethyltransferase, Biochem. Pharmacol. 20: 1363.
Bridger, W. H., and Mandel, I. J., 1967, The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response, Life Sci. 6: 775.
Cantoni, G. L., 1952, The nature of the active methyl donor formed enzymatically from Lmethionine and adenosinetriphosphate, J. Am. Chem. Soc. 74: 2942
Charalampous, K. D., 1971, Comparison of metabolism of mescaline and 3,4dimethoxyphenylethylamine in humans, Behay. Neuropsychiat. 2: 26.
Charalampous, K. D., and Tansey, L. W., 1967, Metabolic fate of 13-(3,4-dimethoxyphenyl)ethylamine in man, J. Pharmacol. Exptl. Therap. 155: 318.
Chang, T., Okerholm, R. A., and Glazko, A. J., 1972, A 3-O-methylated catechol metabolite of diphenylhydantoin (dilantin) in rat urine, Res. Commun Chem. Path. Pharmacol. 4: 13.
Cohn, C. K., Dunner, D. L., and Axelrod, J., 1970, Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder, Science 170: 1323.
Creveling, C. R., Morris, N., Shimizu, H., Ong, H. H., and Daly, J. W., 1972, Catechol-Omethyltransferase IV. Factors affecting m-and pémethylation of substituted catechols, Mol. Pharmacol. 8: 398.
Daly, J. W., and Manian, A. A., 1969, The action of catechol-O-methyltransferase on 7,8dihydroxychlorpromazine-formation of 7-hydroxy-8-methoxychlorpromazine and 8hydroxy-7-methoxy chlorpromazine, Biochem. Pharmacol. 18: 1235.
Daly, J., Axelrod, J., and Witkop, B., 1962, Methylation and demethylation in relation to the in vitro metabolism of mescaline, Ann. N.Y. Acad. Sci. 96: 37.
Daly, J., Inscoe, J. K., and Axelrod, J., 1965, The formation of O-methylated catechols by microsomal hydroxylation of phenol and subsequent enzymatic catechol O-methylation. Substrate specificity, J. Med. Chem. 8: 153.
Dear, E. M. A., and Malcolm, J. L., 1967, A study of the effect of 3,4dimethoxyphenylethylamine on cortical evoked potentials in the rat, Intern. J. Neuropharmacol. 6: 529.
Deguchi, T., and Barchas, J., 1971, Inhibition of transmethylations of biogenic amines by Sadenosylhomocysteine, J. Biol. Chem. 246: 3175.
Ernst, A. M., 1965, Relation between the structure of certain methoxyphenethylamine derivatives and the occurrence of a hypokinetic rigid syndrome, Psychopharmacologia 7: 383.
Faurbye, A., 1968, The role of amines in the etiology of schizophrenia, Comprehensive Psy-chiat. 9:155.
Folkers, K., 1967, Research on coenzyme Q, in: Phenolic Compounds and Metabolic Regulation (B. J. Finkle, and V. C. Runeckles, eds.), p. 94, Appleton-Century-Crofts, New York.
Frere, J. M., and Verly, W. G., 1971, Catechol-O-methyltransferase. The para-and meta-O-methylations of noradrenaline, Biochim. Biophys. Acta 235: 73.
Friedhoff, A. J., and Alpert, M., 1973, A dopaminergic-cholinergic mechanism in production of psychotic symptoms, Biol. Psychiat. 6: 165.
Friedhoff, A. J., and Hollister, L. E., 1966, Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans, Biochem. Pharmacol. 15: 269.
Friedhoff, A. J., and Schweitzer, J. W., 1968, An effect of N-acetyl-dimethoxyphenethylamine, Diseases Nervous System 29: 455.
Friedhoff, A. J., and Van Winkle, E., 1962, Isolation and characterization of a compound from the urine of schizophrenics, Nature 194: 897.
Friedhoff, A. J., and Van Winkle, E., 1963, Conversion of dopamine to 3,4-dimethoxyphenylacetic acid in schizophrenic patients, Nature 199: 1271.
Friedhoff, A. J., and Van Winkle, E., 1964, Biological O-methylation and schizophrenia, Psychiat. Res. Rep. Am. Psychiat. Assoc. 19: 149.
Friedhoff, A. J., Schweitzer, J. W., and Miller, J. C., (1972a). The enzymatic formation of 3,4di-O-methylated dopamine metabolites by mammalian tissues, Res. Commun Chem. Path. Pharmacol. 3: 293.
Friedhoff, A. J., Schweitzer, J. W., and Miller, J., 1972b, Biosynthesis of mescaline and Nacetylmescaline by mammalian liver, Nature 237: 454.
Friedhoff, A. J., Schweitzer, J. W., Miller, J. C., and Van Winkle, E., 1972c, Guaiacol-Omethyltransferase: A mammalian enzyme capable of forming di-O-methylcatecholamine derivatives, Experientia 28: 517.
Fujimori, M., and Alpers, H. S., 1970, Psychotomimetic compounds in man and animals, in: Biochemistry, Schizophrenias, and Affective Illnesses, ( H. E. Himwich, ed.), p. 361, Williams and Wilkins Co., Baltimore.
Gustayson, K. H., Wetterberg, L., Backstrom, M., and Ross, S. B., 1973, Catechol-O-methyl-transferase activity in erythrocytes in Down’s syndrome, Clin. Genet. 4: 279.
Hartley, R., and Smith, J. A., 1973, Formation in vitro of N-acetyl-3,4-dimethoxyphenethylamine by pineal hydroxyindole-O-methyltransferase, Biochem. Pharmacol. 22: 2425.
Hollister, L. E., and Friedhoff, A. J., 1966, Effects of 3,4-dimethoxyphenylethylamine in man, Nature 210: 1377.
Kapadia, G. J., and Fayez, M. B. E., 1970, Peyote constituents: chemistry, biogenesis and biological effects, J. Pharm. Sci. 59: 1699.
Levis, D. J., and Caldwell, D. F., 1971, The effects of a low dose of mescaline and 3,4dimethoxyphenylethylamine under two levels of adversive stimulation, Biol. Psychiat. 3: 251.
Mandell, A. J., and Morgan, M., 1970, Human brain enzyme makes indole hallucinogens, Proc. Am. Psycho!. Assoc. p. 228.
Masri, M. S., Robbins, D. J., Emerson, O. H., and De Eds, F., 1964, Selective para-or metaO-methylation with catechol-O-methyltransferase from rat liver, Nature 202: 878.
Matthysse, S., and Baldessarini, R. J., 1972, S-Adenosylmethionine and catechol-O-methyltransferase in schizophrenia, Am. J. Psychiat. 128: 1310.
McKenzie, G. M., and White, H. L., 1973, Evidence for the methylation of apomorphine by catechol-O-methyltransferase in vivo and in vitro, Biochem. Pharmacol. 22: 2329.
Osmond, H., and Smythies, J., 1952, Schizophrenia: a new approach, J. Mental Sci. 98: 309.
Pollin, W., Cardon, P. V., and Kety, S. S., 1961, Effects of amino acid feeding in schizophrenic patients treated with iproniazid, Science 133: 104.
Price, J., 1969, The metabolites of isovanillic acid in man, with special reference to the formation of 3,4-dimethoxybenzoic acid, Clin. Chim. Acta 25: 31.
Schweitzer, J. W., and Friedhoff, A. J., 1966, The metabolism of a-C-3,4dimethoxyphenethylamine, Biochem. Pharmacol. 15: 2097.
Schweitzer, J. W., Stone, E. A., and Friedhoff, A. J., 1973, Increased in vitro O-methylation in swim-stressed rats, Presented at the 4th meeting of the International Society for Neurochemistry, Tokyo.
Shulgin, A. T., Sargent, T., and Naranjo, C., 1969, Structure-activity relationships of one-ring psychotomimetics, Nature 221: 537.
Smythe, G. A., and Lazarus, L., 1973, Blockade of the dopamine-inhibitory control of prolactin secretion in rats by 3,4-dimethoxyphenylethylamine (3,4-di-O-methyldopamine), Endocrinology 93: 147.
Snyder, S. H., and Merril, C. R., 1965, A relationship between the hallucinogenic activity of drugs and their electronic configuration, Proc. Natl. Acad. Sci. (U.S.) 54: 258.
Takeo, Y., and Himwich, H. E., 1965, Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: sites of electroencephalographic arousal, Science 150: 1309.
Vacca, L., Fujimori, M., Davis, S. H., and Marrazzi, A. S., 1968, Cerebral synaptic transmission and behavioral effects of dimethoxyphenylethylamine: a potential psychotogen, Science 160: 95.
Van Praag, H. M., 1967, The possible significance of cerebral dopamine for neurology and psychiatry, Psychiat. Neurol. Neurochir. 70: 361.
Weil-Malherbe, H., and Szara, S. I., 1971, The Biochemistry of Functional and Experimental Psychoses, Charles C. Thomas, Springfield.
Wyatt, R. J., Termini, B. A., and Davis, J., 1971, Biochemical and sleep studies of schizophrenia: a reveiw of the literature-1960–1970. Part I. Biochemical studies, Schizophrenia Bull. 4: 10.
Youdim, M. B. H., Collins, C. G. S., and Sandler, M., 1969, Multiple forms of rat brain monoamine oxidase, Nature 223: 626.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Friedhoff, A.J., Schweitzer, J.W. (1975). Mammalian Biosynthesis of Potential Psychotogens Derived from Dopamine. In: Friedhoff, A.J. (eds) Catecholamines and Behavior · 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3135-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3135-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3137-7
Online ISBN: 978-1-4684-3135-3
eBook Packages: Springer Book Archive